Company: NDRA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001654954-25-009643
Chunk: 0

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
ENDRA Life Sciences Inc.

Condensed Consolidated Balance Sheets

Assets June 30,2025  December 31,2024 Current Assets (Unaudited)    Cash $1,808,574  $3,229,480 Prepaid expenses  44,310   204,185 Total Current Assets  1,852,884   3,433,665 Non-Current Assets        Fixed assets, net  63,419   69,281 Right of use assets  519,966   578,013 Prepaid expenses, long term  365,417   365,417 Other assets  5,986   5,986          Total Assets $2,807,672  $4,452,362          Liabilities and Stockholders’ Equity        Current Liabilities        Accounts payable and accrued liabilities $448,419  $508,293 Lease liabilities, current portion  128,218   96,937 Total Current Liabilities  576,637   605,230          Long Term Debt        Lease liabilities  429,274   487,482 Warrant Liability  328,610   799,284 Total Long Term Debt  757,884   1,286,766          Total Liabilities  1,334,521   1,891,996          Stockholders’ Equity        Series A Convertible Preferred Stock, $0.0001 par value; 10,000 shares authorized; 17,488 and 17,488 shares  -   - 

issued and outstanding, respectively      Series B Convertible Preferred Stock, $0.0001 par value; 1,000 shares authorized; no shares issued and      outstanding  -   - Series C Preferred Stock, $0.0001 par value; 100,000 shares authorized; no shares issued and outstanding  -   - Common stock, $0.0001 par value; 20,000,000 shares authorized; 752,390 and 536,908 shares issued and        outstanding, respectively  74   53 Additional paid in capital  107,173,418   105,998,412 Stock payable  -   - Accum